These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
475 related articles for article (PubMed ID: 26159261)
1. How to Diagnose and Exclude Drug-Induced Liver Injury. Watkins PB Dig Dis; 2015; 33(4):472-6. PubMed ID: 26159261 [TBL] [Abstract][Full Text] [Related]
2. Causality assessment for suspected DILI during clinical phases of drug development. Regev A; Seeff LB; Merz M; Ormarsdottir S; Aithal GP; Gallivan J; Watkins PB Drug Saf; 2014 Nov; 37 Suppl 1(Suppl 1):S47-56. PubMed ID: 25352327 [TBL] [Abstract][Full Text] [Related]
3. [Clinical and pathological features in 138 cases of drug-induced liver injury]. Lai RT; Wang H; Gui HL; Ye MZ; Dai WJ; Xiang XG; Zhao GD; Wang WJ; Xie Q Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):185-9. PubMed ID: 22475136 [TBL] [Abstract][Full Text] [Related]
4. Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method. Teschke R Expert Opin Drug Metab Toxicol; 2018 Nov; 14(11):1169-1187. PubMed ID: 30354694 [TBL] [Abstract][Full Text] [Related]
5. Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment? Teschke R; Schulze J; Eickhoff A; Danan G Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398242 [TBL] [Abstract][Full Text] [Related]
6. A detection algorithm for drug-induced liver injury in medical information databases using the Japanese diagnostic scale and its comparison with the Council for International Organizations of Medical Sciences/the Roussel Uclaf Causality Assessment Method scale. Hanatani T; Sai K; Tohkin M; Segawa K; Kimura M; Hori K; Kawakami J; Saito Y Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):984-8. PubMed ID: 24596340 [TBL] [Abstract][Full Text] [Related]
7. Role of liver biopsy in the era of clinical prediction scores for "drug-induced liver injury" (DILI): experience of a tertiary referral hospital. Costa-Moreira P; Gaspar R; Pereira P; Lopes S; Canão P; Lopes J; Carneiro F; Macedo G Virchows Arch; 2020 Oct; 477(4):517-525. PubMed ID: 32377873 [TBL] [Abstract][Full Text] [Related]
8. Clinical features, diagnosis, and natural history of drug-induced liver injury. Hayashi PH; Fontana RJ Semin Liver Dis; 2014 May; 34(2):134-44. PubMed ID: 24879979 [TBL] [Abstract][Full Text] [Related]
9. Characteristic molecular and proteomic signatures of drug-induced liver injury in a rat model. Eun JW; Bae HJ; Shen Q; Park SJ; Kim HS; Shin WC; Yang HD; Jin CY; You JS; Kang HJ; Kim H; Ahn YM; Park WS; Lee JY; Nam SW J Appl Toxicol; 2015 Feb; 35(2):152-64. PubMed ID: 25231249 [TBL] [Abstract][Full Text] [Related]
10. The Liver Toxicity Knowledge Base (LKTB) and drug-induced liver injury (DILI) classification for assessment of human liver injury. Thakkar S; Chen M; Fang H; Liu Z; Roberts R; Tong W Expert Rev Gastroenterol Hepatol; 2018 Jan; 12(1):31-38. PubMed ID: 28931315 [TBL] [Abstract][Full Text] [Related]
11. Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method. Teschke R; Méndez-Sánchez N; Eickhoff A Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563242 [TBL] [Abstract][Full Text] [Related]
12. Hepatotoxicity by Drugs: The Most Common Implicated Agents. Björnsson ES Int J Mol Sci; 2016 Feb; 17(2):224. PubMed ID: 26861310 [TBL] [Abstract][Full Text] [Related]
16. Incidence and Etiology of Drug-Induced Liver Injury in Mainland China. Shen T; Liu Y; Shang J; Xie Q; Li J; Yan M; Xu J; Niu J; Liu J; Watkins PB; Aithal GP; Andrade RJ; Dou X; Yao L; Lv F; Wang Q; Li Y; Zhou X; Zhang Y; Zong P; Wan B; Zou Z; Yang D; Nie Y; Li D; Wang Y; Han X; Zhuang H; Mao Y; Chen C Gastroenterology; 2019 Jun; 156(8):2230-2241.e11. PubMed ID: 30742832 [TBL] [Abstract][Full Text] [Related]
17. Drug properties and host factors contribute to biochemical presentation of drug-induced liver injury: a prediction model from a machine learning approach. Gonzalez-Jimenez A; Suzuki A; Chen M; Ashby K; Alvarez-Alvarez I; Andrade RJ; Lucena MI Arch Toxicol; 2021 May; 95(5):1793-1803. PubMed ID: 33666709 [TBL] [Abstract][Full Text] [Related]
18. [Current status of Chinese herbal preparations included in LiverTox database]. Jin R; Gu HY; Li LL; Sun LL Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):817-823. PubMed ID: 27978926 [No Abstract] [Full Text] [Related]
19. Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch? Danan G; Teschke R Drug Saf; 2018 Aug; 41(8):735-743. PubMed ID: 29502198 [TBL] [Abstract][Full Text] [Related]
20. A revised electronic version of RUCAM for the diagnosis of DILI. Hayashi PH; Lucena MI; Fontana RJ; Bjornsson ES; Aithal GP; Barnhart H; Gonzalez-Jimenez A; Yang Q; Gu J; Andrade RJ; Hoofnagle JH Hepatology; 2022 Jul; 76(1):18-31. PubMed ID: 35014066 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]